Synthesis and structure assignment of the minor metabolite arising from the frog pathogen Mycobacterium liflandii

Tetrahedron Letters

Volumn 51, Issue 13, 2010, Pages 1782-1785

  Spangenberg, Thomas ^a   Aubry, Sylvain ^a   Kishi, Yoshito ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; MYCOLACTONE; MYCOLACTONE A; MYCOLACTONE B; MYCOLACTONE C; MYCOLACTONE D; MYCOLACTONE E; MYCOLACTONE F; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; FROG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MYCOBACTERIUM; MYCOBACTERIUM LIFLANDII;

ANURA; MYCOBACTERIUM LIFLANDII;

EID: 76949094508     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2010.01.105     Document Type: Article

References (34)

1. For general reviews on Buruli ulcer for example see:. Asiedu K., and Scherpbier R. In: Ravinglione M. (Ed). Buruli ulcer: Mycobacterium ulcerans infection (2000), World Health Organization, Geneva, Switzerland
2. van der Werf T.S., Stinear T., Stienstra Y., van der Graaf W.T.A., and Small P.L. Lancet 362 (2003) 1062
3. Johnson P.D.R., Stinear T., Small P.L.C., Pluschke G., Merritt R.W., Portaels F., Huygen K., Hayman J.A., and Asiedu K. PLoS Med. 2 (2005) e108
4. van der Werf T.S., Stienstra Y., Johnson R.C., Phillips R., Adjei O., Fleischer B., Wansbrough-Jones M.H., Johnson P.D.R., Portaels F., van der Graaf W.T.A., and Asiedu K. Bull. World Health Org. 83 (2005) 785
5. Hong H., Demangel C., Pidot S.J., Leadlay P.F., and Stinear T. Nat. Prod. Rep. (2008) 447
6. Demangel C., Stinear T.P., and Cole S.T. Nat. Rev. Microbiol. 7 (2009) 50
7. George K.M., Chatterjee D., Gunawardana G., Welty D., Hayman J., Lee R., and Small P.L.C. Science 283 (1999) 854
8. For the gross-structure of mycolactone A/B, see:. Gunawardana G., Chatterjee D., George K.M., Brennan P., Whittern D., and Small P.L.C. J. Am. Chem. Soc. 121 (1999) 6092
9. For the stereochemistry of mycolactone A/B, see:. Benowitz A.B., Fidanze S., Small P.L.C., and Kishi Y. J. Am. Chem. Soc. 123 (2001) 5128
10. Fidanze S., Song F., Szlosek-Pinaud M., Small P.L.C., and Kishi Y. J. Am. Chem. Soc. 123 (2001) 10117
11. For the total synthesis of mycolactone A/B. See:. Song F., Fidanze S., Benowitz A.B., and Kishi Y. Org. Lett. 4 (2002) 647 and Tetrahedron, 2007, 63, 5739
12. George K.M., Pascopella L., Welty D.M., and Small P.L.C. Infect. Immun. 68 (2000) 877
13. For mycolactone C, see: (a) the isolation and gross-structure:. Mve-Obiang A., Lee R.E., Portaels F., and Small P.L.C. Infect. Immun. 71 (2003) 774
14. the stereochemistry and total synthesis:. Judd T.C., Bischoff A., Kishi Y., Adusumilli S., and Small P.L.C. Org. Lett. 6 (2004) 4901
15. Hong H., Spencer J.B., Porter J.L., Leadlay P.F., and Stinear T. ChemBioChem 6 (2005) 643
16. For mycolactone F, see: (a) isolation and gross-structure:. Ranger B.S., Mahrous E.A., Mosi L., Adusumilli S., Lee R.E., Colorni A., Rhodes M., and Small P.L.C. Infect. Immun. 74 (2006) 6037
17. Hong H., Stinear T., Porter J., Demangel C., and Leadlay P.F. ChemBioChem 8 (2007) 2043
18. stereochemistry and total synthesis of mycolactone F isolated from the saltwater fish pathogen M. marinum:. Kim H.-J., and Kishi Y. J. Am. Chem. Soc. 130 (2008) 1842
19. stereochemistry and total synthesis of mycolactone F isolated from the freshwater fish pathogen M. marinum:. Kim H.-J., Jackson K.L., Kishi Y., Williamson H.R., Mosi L., and Small P.L.C. Chem. Commun. (2009) 7402
20. Trott K.A., Stacy B.A., Lifland B.D., Diggs H.E., Harland R.M., Khokha M.K., Grammer T.A., and Parker J.M. Comp. Med. 54 (2004) 309
21. For mycolactone E, see: (a) isolation and gross-structure:. Hong H., Stinear T., Skelton P., Spencer J.B., and Leadlay P.F. Chem. Commun. (2005) 4306
22. and. Mve-Obiang A., Lee R.E., Umstot E.S., Trott K.A., Grammer T.C., Parker J.M., Ranger B.S., Grainger R., Mahrous E.A., and Small P.L.C. Infect. Immun. 73 (2005) 3307
23. stereochemistry and total synthesis:. Aubry S., Lee R.E., Mahrous E.A., Small P.L.C., Beachboard D., and Kishi Y. Org. Lett. 10 (2008) 5385
24. 11a The total amount of mycolactones present in this extract was estimated to be equivalent with ∼10 injections for HPLC analysis.
25. For a recent review on anion-relay-chemistry see:. Smith III A.B., and Wuest W.M. Chem. Commun. (2008) 5883
26. For the preparation of TBS-1,3-dithiane see:. Silverman R.B., Lu X., and Banik G.M. J. Org. Chem. 57 (1992) 6617
27. For dihydroxylation of sulfur containing substrates, see for example:. Walsh P.J., Ho P.T., King S.B., and Sharpless K.B. Tetrahedron Lett. 35 (1994) 5129
28. Sammakia T., Hurley B., Sammond D.M., Smith R.S., Sobolov S.B., and Oeschger T.R. Tetrahedron Lett. 37 (1996) 4427
29. The core alcohol 2 was synthesized by Dr. Han-Je Kim in this laboratory.
30. Corey E.J., and Erickson B.W. J. Org. Chem. 36 (1971) 3553
31. TBAF tested included: TBAF (Aldrich) as supplied and TBAF buffered with imidazole hydrochloride and AcOH.
32. Kaburagi Y., and Kishi Y. Org. Lett. 9 (2007) 723
33. This test was performed by Dr. Katrina L. Jackson in this laboratory. The complete data will be reported elsewhere.
34. Using the initial solvent conditions described for mycolactone E (benzene/EtOH 98.5:1.5) resulted in the overlap of several peaks, see Supplementary data.